Amanda Garofalo Appointed Senior Vice President of Clinical Operations at TuHURA Biosciences

TuHURA Biosciences has announced the appointment of Amanda Garofalo, MSHS, as its new Senior Vice President of Clinical Operations. The company confirmed the leadership change on Tuesday, April 7, 2026. Garofalo will oversee clinical operations at TuHURA Biosciences, bringing her expertise to support the organization’s ongoing and future initiatives.

Garofalo holds a Master of Science in Health Sciences (MSHS) and has extensive experience in clinical operations management. Her role will involve directing clinical trials and ensuring regulatory compliance while contributing to the company’s broader strategic goals. TuHURA Biosciences specializes in advancing biotechnological solutions, and this appointment marks a significant step in strengthening its leadership team.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 7, 2026

Author

GOAI